Continued Search for Therapies to Favorably Modify Phosphate and FGF23 Levels in CKD

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1911-1913. doi: 10.2215/CJN.11011017. Epub 2017 Oct 26.
No abstract available

Keywords: Atrial Fibrillation; CKD; Cardiovascular Diseases; Fibroblast Growth Factors; Humans; Hypertrophy, Left Ventricular; Inflammation; Leukocytes; Myocytes, Cardiac; Phosphates; Renal Insufficiency, Chronic; fibroblast growth factor 23; heart failure; hyperphosphatemia; phosphate binders; risk factors.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors
  • Humans
  • Phosphates*
  • Renal Insufficiency, Chronic
  • Sevelamer*

Substances

  • FGF23 protein, human
  • Phosphates
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Sevelamer